We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
+37.45%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$192M
AUM Growth
+$33.8M
Cap. Flow
+$12.5M
Cap. Flow %
6.52%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$13M
2
MGNX icon
MacroGenics
MGNX
+$2.01M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$2.45M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$142M 73.83%
3,833,999
+352,400
+10% +$13M
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$33.7M 17.52%
2,880,702
– –
ESPR
3
DELISTED
Esperion Therapeutics
ESPR
$14.5M 7.53%
289,100
-50,900
-15% -$2.45M
MGNX icon
4
MacroGenics
MGNX
$263M
$2.14M 1.11%
+115,914
New +$2.01M

Similar funds

MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return

Aviva Holdings's Q3 2017 Portfolio in Review

As of Q3 2017, Aviva Holdings held 4 positions worth $192M, up 21% from $159M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings deployed $12.5M of net new capital in Q3 2017, opening 1 new position and adding to 1 existing holding. Its largest new stake was MacroGenics: 115,914 shares worth $2.14M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Esperion Therapeutics, an estimated $2.45M trimmed.

  • Aviva Holdings's largest Q3 2017 buy was MacroGenics: 115,914 shares worth $2.14M.
  • Aviva Holdings added most to Medicines Co in Q3 2017, an estimated $13M increase.
  • Aviva Holdings's biggest Q3 2017 reduction was Esperion Therapeutics, cutting an estimated $2.45M.
  • Aviva Holdings's ten largest holdings make up 100% of its $192M portfolio in Q3 2017.
  • Aviva Holdings opened 1 new position and closed 0 in Q3 2017.
  • Aviva Holdings's portfolio value rose 21% quarter-over-quarter to $192M.

Based on Aviva Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.